Literature DB >> 10612010

Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer.

J Lachaine1, C Laurier, A Langleben, L Vaillant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10612010     DOI： 10.1016/s1040-8428(99)00025-6

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  8 in total

Review 1.  Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.

Authors:  L A Sanchez; M Holdsworth; S B Bartel
Journal:  Pharmacoeconomics       Date:  2000-12       Impact factor: 4.981

Review 2.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

Review 3.  The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy-Induced Nausea and Vomiting: Systematic Review of the Literature.

Authors:  Michael S Broder; Claudio Faria; Annette Powers; Jehangeer Sunderji; Dasha Cherepanov
Journal:  Am Health Drug Benefits       Date:  2014-05

4.  Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.

Authors:  Nisreen Hassan; R K Khar; Mushir Ali; Javed Ali
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

Review 5.  A clinical perspective on mucoadhesive buccal drug delivery systems.

Authors:  Ritu M Gilhotra; Mohd Ikram; Sunny Srivastava; Neeraj Gilhotra
Journal:  J Biomed Res       Date:  2013-06-06

6.  Economic Evaluation of a New Antiemetic Drug - Palonosetron versus Ondansetron : Assessment of the Drug Price Ratio in Five European Countries.

Authors:  Rosanna Tarricone; Federica Girolami
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 3.580

Review 7.  Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

Authors:  Ali Montazeri
Journal:  J Exp Clin Cancer Res       Date:  2008-08-29

Review 8.  Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy.

Authors:  Enzo Ballatori; Fausto Roila
Journal:  Health Qual Life Outcomes       Date:  2003-09-17       Impact factor: 3.186
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.